Fennec Pharmaceuticals Inc.(FENC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FENC Fennec Pharmaceuticals Inc.

盘前交易 07-17 04:26:40 EDT

6.73

+0.19

+2.91%

最高6.82	最低6.52	成交量7.74万
今开6.52	昨收6.54	日振幅4.59%
总市值1.84亿	流通市值8,933万	总股本2,733万
成交额51.86万	换手率0.58%	流通股本1,327万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"FENC","market":"US","secType":"STK","nameCN":"Fennec Pharmaceuticals Inc.","latestPrice":6.73,"timestamp":1721160000000,"preClose":6.54,"halted":0,"volume":77372,"delay":0,"floatShares":13273308,"shares":27328428,"eps":0.105081,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.19,"latestTime":"07-17 04:26:40 EDT","open":6.52,"high":6.82,"low":6.52,"amount":518626.62051840004,"amplitude":0.045872,"askPrice":7.5,"askSize":250,"bidPrice":2.7,"bidSize":200,"shortable":3,"etf":0,"ttmEps":0.105081,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721223000000},"adr":0,"adjPreClose":6.73,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":6.73,"preClose":6.73,"latestTime":"16:53 EDT","volume":3985,"amount":26815.2031,"timestamp":1721163235373},"volumeRatio":1.0694480516419587,"impliedVol":0.048,"impliedVolPercentile":0.008},"requestUrl":"/m/hq/s/FENC/tweets","defaultTab":"tweets","newsList":[{"id":"2435636492","title":"HC Wainwright & Co.：维持Fennec Pharmaceuticals(FENC.US)评级，由买入调整至买入评级, 目标价由18.00美元调整至15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435636492","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435636492?lang=zh_cn&edition=full","pubTime":"2024-05-15 19:16","pubTimestamp":1715771795,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Fennec Pharmaceuticals(FENC.US)评级，由买入调整至买入评级, 目标价由18.00美元调整至15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151916378b0b1f18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151916378b0b1f18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC"],"gpt_icon":0},{"id":"2433896457","title":"Fennec Pharmaceuticals Inc   预计每股收益26美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433896457","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433896457?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:55","pubTimestamp":1715093752,"startTime":"0","endTime":"0","summary":"   * Fennec Pharmaceuticals Inc    预计将在5月9日公布截至2024年3月31日的业绩(估计)，季度收入将有所增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于北卡罗来纳州三角研究园的公司的营收有望从去年同期的168万美元增长1025.6%，达到1887.6万美元。* LSEG 分析师对 Fennec Pharmaceuticals Inc 的平均预期为每股收益 26 美分。* 华尔街对 Fennec Pharmaceuticals Inc 的 12 个月目标价中位数为 18.00 美元，高于其最新收盘价 9.09 美元。5月7日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FENC"],"gpt_icon":0},{"id":"2428373010","title":"Fennec Pharmaceuticals Inc.盘中异动 股价大跌5.07%报9.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428373010","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428373010?lang=zh_cn&edition=full","pubTime":"2024-04-18 03:54","pubTimestamp":1713383670,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日03时54分，Fennec Pharmaceuticals Inc.股票出现波动，股价快速下跌5.07%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家临床阶段的生物技术公司。消息层面，截至03时54分，《Form 144 | Fennec Pharmaceuticals高管拟出售2.22万股股份，价值约22.88万美元》资讯为影响Fennec Pharmaceuticals Inc.的重要信息。该信息摘要如下：根据美国证券交易委员会美东时间4月15日披露的文件，$Fennec Pharmaceuticals $高管ADRIAN J HAIGH拟于4月15日出售2.22万股普通股股份，总市值约22.88万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404180354307921482f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404180354307921482f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2421830006","title":"Fennec Pharmaceuticals Inc.2023财年实现净利润-16.05百万美元，同比增加32.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421830006","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421830006?lang=zh_cn&edition=full","pubTime":"2024-03-22 06:18","pubTimestamp":1711059495,"startTime":"0","endTime":"0","summary":"12月31日，Fennec Pharmaceuticals Inc.公布财报，公告显示公司2023财年净利润为-16.05百万美元，同比增加32.31%；其中营业收入为21.25百万美元，同比增加1279.87%，每股基本收益为-0.60美元。机构评级：截至2023年12月31日，当前有4家机构对Fennec Pharmaceuticals Inc.目标价做出预测，其中目标均价为16.50美元，其中最低目标价为16.00美元，最高目标价为18.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403220618178b528895&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403220618178b528895&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC"],"gpt_icon":0},{"id":"2415052618","title":"Fennec Pharmaceuticals Inc.盘中异动 早盘股价大涨6.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415052618","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2415052618?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:44","pubTimestamp":1709217865,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日22时44分，Fennec Pharmaceuticals Inc.股票出现异动，股价快速拉升6.87%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为1.04%。其相关个股中，Carmell Corp C/Wts 12/07/2028 、Enveric Biosciences, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Enveric Biosciences, Inc.、Adial Pharmaceuticals, Inc、Scisparc Ltd.较为活跃，换手率分别为2057.91%、114.77%、54.18%，振幅较大的相关个股有Carmell Corp C/Wts 12/07/2028 、Enveric Biosciences, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为81.15%、51.74%、34.76%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292244267915f927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292244267915f927&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2411656302","title":"Fennec Pharmaceuticals Inc盘中异动 股价大涨6.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411656302","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411656302?lang=zh_cn&edition=full","pubTime":"2024-02-14 22:33","pubTimestamp":1707921183,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日22时33分，Fennec Pharmaceuticals Inc股票出现异动，股价急速拉升6.28%。Fennec Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Engene Holdings Inc、Engene Holdings Inc C/Wts 31/10/2028  Cl A、Cogent Biosciences Inc涨幅较大，Azitra Inc、Kintara Therapeutics Inc、Fresh2 Group Limited较为活跃，换手率分别为15.48%、14.98%、11.48%，振幅较大的相关个股有Engene Holdings Inc C/Wts 31/10/2028  Cl A、Fresh2 Group Limited、Cogent Biosciences Inc，振幅分别为20.43%、12.69%、12.45%。Fennec Pharmaceuticals Inc公司简介：Fennec Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402142233047a43a503&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402142233047a43a503&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2411605163","title":"Fennec Pharmaceuticals Inc盘中异动 急速跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411605163","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411605163?lang=zh_cn&edition=full","pubTime":"2024-02-14 01:42","pubTimestamp":1707846126,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日01时42分，Fennec Pharmaceuticals Inc股票出现波动，股价急速下跌5.06%。Fennec Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为0.64%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 、Zura Bio Limited C/Wts 20/03/2028 涨幅较大，Biodexa Pharmaceuticals Plc、Revelation Biosciences Inc、Adial Pharmaceuticals Inc较为活跃，换手率分别为422.44%、207.89%、128.22%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Renovaro Biosciences Inc、Calidi Biotherapeutics Inc，振幅分别为53.85%、51.26%、50.00%。Fennec Pharmaceuticals Inc公司简介：Fennec Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021401420779114135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021401420779114135&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2406957097","title":"Fennec Pharmaceuticals Inc盘中异动 快速下跌5.85%报9.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2406957097","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2406957097?lang=zh_cn&edition=full","pubTime":"2024-01-26 22:32","pubTimestamp":1706279533,"startTime":"0","endTime":"0","summary":"北京时间2024年01月26日22时32分，Fennec Pharmaceuticals Inc股票出现波动，股价大幅下跌5.85%。截至发稿，该股报9.81美元/股，成交量2.2922万股，换手率0.09%，振幅0.94%。Fennec Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Corbus Pharmaceuticals Holdings In、Panbela Therapeutics Inc、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Panbela Therapeutics Inc、Tc Biopharm  Plc、Processa Pharmaceuticals Inc较为活跃，换手率分别为1050.79%、911.93%、447.53%，振幅较大的相关个股有Corbus Pharmaceuticals Holdings In、Dermata Therapeutics Inc、Cns Pharmaceuticals Inc，振幅分别为29.03%、17.75%、14.89%。Fennec Pharmaceuticals Inc公司简介：Fennec Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012622321381e6c58d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012622321381e6c58d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fennecpharma.com","stockEarnings":[{"period":"1week","weight":0.1485},{"period":"1month","weight":-0.0044},{"period":"3month","weight":-0.3062},{"period":"6month","weight":-0.335},{"period":"1year","weight":-0.2309},{"period":"ytd","weight":-0.4002}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1285},{"period":"6month","weight":0.1855},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.1884}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fennec Pharmaceuticals Inc.最初是作为一家英属哥伦比亚公司成立的，其名称是“粘着”技术公司，随后于2014年9月3日改名。Fennec和它的全资子公司氧化奎特公司(“氧化物”)和Fennec制药公司，以及加拿大的一家加拿大公司(简称“CBI”)，在这里被统称为“公司”，是一家生物制药公司，有一个正在开发中的产品，用于治疗癌症。该公司是一家生物制药公司，主要关注硫代硫酸钠(“STS”)的开发，以预防小儿癌症患者体内铂中毒的毒性。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.012234},{"month":2,"riseRate":0.571429,"avgChangeRate":0.018842},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.020679},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.021313},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.031154},{"month":6,"riseRate":0.428571,"avgChangeRate":0.018884},{"month":7,"riseRate":0.714286,"avgChangeRate":0.03761},{"month":8,"riseRate":0.5,"avgChangeRate":-0.036198},{"month":9,"riseRate":0.666667,"avgChangeRate":0.058778},{"month":10,"riseRate":0.428571,"avgChangeRate":0.012399},{"month":11,"riseRate":0.714286,"avgChangeRate":-0.002651},{"month":12,"riseRate":0.571429,"avgChangeRate":0.038013}],"exchange":"NASDAQ","name":"Fennec Pharmaceuticals Inc.","nameEN":"Fennec Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.0","shortVersion":"4.25.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fennec Pharmaceuticals Inc.(FENC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fennec Pharmaceuticals Inc.(FENC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fennec Pharmaceuticals Inc.,FENC,Fennec Pharmaceuticals Inc.股票,Fennec Pharmaceuticals Inc.股票老虎,Fennec Pharmaceuticals Inc.股票老虎国际,Fennec Pharmaceuticals Inc.行情,Fennec Pharmaceuticals Inc.股票行情,Fennec Pharmaceuticals Inc.股价,Fennec Pharmaceuticals Inc.股市,Fennec Pharmaceuticals Inc.股票价格,Fennec Pharmaceuticals Inc.股票交易,Fennec Pharmaceuticals Inc.股票购买,Fennec Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fennec Pharmaceuticals Inc.(FENC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fennec Pharmaceuticals Inc.(FENC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}